MAIA

Beyond's analysis on MAIA

• 2026-09-22 — MAIA Biotechnology accelerates Phase 3 clinical trials for advanced lung cancer treatment through rapid patient enrollment

Recent news mentioning MAIA

• 2026-09-23 — MAIA Biotechnology Expands Pivotal Phase 3 THIO-104 Non-Small Cell Lung Cancer Trial into Spain and Portugal
• 2026-09-22 — MAIA Biotechnology Reports Pivotal Phase 3 Clinical Trial Progress in Advanced Non-Small Cell Lung Cancer
• 2026-09-16 — MAIA Biotechnology Doses First U.S. Patient in Ongoing Phase 2 Non-Small Cell Lung Cancer Clinical Trial
• 2026-09-15 — MAIA Biotechnology Announces Open Market Purchases of Company Stock by Long-Standing Board Member and CEO
• 2026-09-10 — MAIA Biotechnology Delivers Oral and Poster Presentations Showcasing Next-Generation Telomere-Targeting Cancer Therapies at IRT 2026
• 2026-09-04 — Sébastien Lecornu inaugure l’usine de fusées réutilisables de MaiaSpace à Vernon
• 2026-08-24 — Tysons, Virginia Plastic Surgeon Dr. Munique Maia Introduces the MAIA Method for Deep Plane Facelift and Comprehensive Facial Rejuvenation
• 2026-08-16 — Microsoft's Maia 300 Chip Targets NVIDIA's AI Dominance

Appears alongside

• IRT

Browse the full archive →